Literature DB >> 34049327

Quality Indicators for the Diagnosis and Management of Sudden Sensorineural Hearing Loss.

Justin Cottrell1, Siraj K Zahr2, Jonathan Yip1, Sumit Agrawal3, Jason Archibald4, Justin Chau5, Jane Lea6, Vincent Lin1, Paul Mick7, David Morris8, Lorne Parnes3, David Schramm9, Yvonne Chan1, John de Almeida1, Antoine Eskander1, Ian J Witterick1, Eric Monteiro1.   

Abstract

OBJECTIVE: Sudden sensorineural hearing loss (SSNHL) is an ideal entity for quality indicator (QI) development, providing treatment challenges resulting in variable or substandard care. The American Academy of Otolaryngology-Head and Neck Surgery recently updated their SSNHL guidelines. With SSNHL demonstrating a large burden of illness, this study sought to leverage the updated guidelines and develop QIs that support quality improvement initiatives at an individual, institutional, and systems level.
METHODS: Candidate indicators (CIs) were extracted from high-quality SSNHL guidelines that were evaluated using the Appraisal of Guidelines for Research and Evaluation II tool. Each CI and its supporting evidence were summarized and reviewed by a nine-member expert panel based on validity, reliability, and feasibility of measurement. Final QIs were selected from CIs using the modified RAND Corporation-University of California, Los Angeles appropriateness methodology.
RESULTS: Fifteen CIs were identified after literature review. After the first round of evaluations, the panel agreed on 11 candidate indicators as appropriate QIs with 2 additional CIs suggested for consideration. An expert panel meeting provided a platform to discuss areas of disagreement before final evaluations. The expert panel subsequently agreed upon 11 final QIs as appropriate measures of high-quality care for SSNHL.
CONCLUSION: The 11 proposed QIs from this study are supported by evidence and expert consensus, facilitating measurement across a wide breadth of quality domains. With the recently updated SSNHL guidelines, and a greater focus on quality improvement opportunities, these QIs may be used by healthcare providers for targeted quality improvement initiatives.
Copyright © 2021, Otology & Neurotology, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34049327     DOI: 10.1097/MAO.0000000000003205

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  1 in total

1.  Clinical Efficacy of Retroauricular Injection of Methylprednisolone Sodium Succinate in the Treatment of Sudden Deafness with Type 2 Diabetes.

Authors:  Zhenbo Zhong; Xiaofei Wang; Kairui Xu; Jing Tao
Journal:  Comput Math Methods Med       Date:  2022-07-22       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.